Peptide supplement searches increased 6x year over year from April 2025 to March 2026, according to search trend data. The compound class has moved from clinical and research settings into mainstream consumer awareness faster than almost any ingredient category in the past decade.
The consumer question that follows that growth is the right one: what does the research actually show? The honest answer is that it depends entirely on which peptide you are asking about, and at what dose, in what delivery format, with what level of manufacturing quality behind it.
Not all peptides are equivalent. The term covers an enormous range of compounds — from simple dipeptides found in food to complex engineered sequences designed for specific receptor interactions. The research quality varies accordingly. Some compound classes have decades of peer-reviewed publication behind them. Others have minimal evidence beyond manufacturer-funded studies.
The strongest evidence base in skin-focused peptide research belongs to the Khavinson-lineage bioregulator compounds — short-chain peptides of two to seven amino acids with tissue-specific gene expression activity documented across 53 years of published research. GHK-Cu alone has appeared in over 50 years of continuous publication, with documented effects on collagen synthesis, fibroblast activation, and dermal regeneration.
PDRN — polydeoxyribonucleotide derived from salmon DNA — has a comparable evidence base in barrier repair and wound cascade activation. Named among the top-trending skincare ingredients globally in 2025, PDRN's A2A adenosine receptor mechanism is well-documented in peer-reviewed literature.
What separates evidence-backed peptide compounds from the broader supplement category is specificity. The mechanism is named, the receptor is identified, the tissue target is documented, and the research is independently published and indexed. That is the standard that every peptide claim should be evaluated against — and it is the standard the HelioMend Khavinson Collection is built on.
The research archive for all compounds used in HelioMystique protocols is publicly accessible at endogenicpharmacology.com. Every compound, every mechanism, every published citation — available to any visitor who wants to follow the science to its source.